论文部分内容阅读
卡兰片主要成分阿朴长春胺酸乙脂(Vinpocetine),是从夹竹桃科小蔓长春花(Vincaminor.r)中提取的生物碱的衍生物之一,由日本武田药品工业株式会社生产,并提供我院临床使用。据报导卡兰片具有松弛血管平滑肌,选择性扩张脑血管和改善脑代谢等作用,并能降低血小板聚集性粘附性。本研究观察了30例脑卒中后遗症和脑动脉硬化患者服用卡兰片2个月的临床疗效和卡兰片对部分病例血小板聚集性的影响,现将结果报告如下。
The main component of Kalam tablets is Vinpocetine, which is one of the derivatives of alkaloids extracted from Vincaminr.r. and produced by Takeda Pharmaceutical Industry Co., Ltd. of Japan. And provide clinical use in our hospital. It has been reported that Karan tablets have relaxing vascular smooth muscle, selective expansion of cerebral blood vessels and improvement of brain metabolism, and can reduce platelet aggregate adhesion. In this study, we observed the clinical efficacy of 30 patients with stroke sequelae and cerebral arteriosclerosis taking Karan tablets for 2 months and the effect of kalan tablets on platelet aggregation in some cases. The results are reported below.